Alcaftadine Patent Expiration
Alcaftadine is Used for temporarily relieving itchy eyes caused by allergens such as pollen, ragweed, grass, animal hair, and dander. It was first introduced by Abbvie Inc
Alcaftadine Patents
Given below is the list of patents protecting Alcaftadine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lastacaft | US10617695 | Ophthalmic compositions containing alcaftadine | Mar 19, 2027 | Abbvie |
| Lastacaft | US5468743 | Imidazo[2,1-b]benzazepine derivatives, compositions and method of use |
Nov 21, 2013
(Expired) | Abbvie |
| Lastacaft | US8664215 | Ocular allergy treatments with alcaftadine | Dec 23, 2027 | Abbvie |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Alcaftadine Generics
Several generic applications have been filed for Alcaftadine. The first generic version for Alcaftadine was by Eugia Pharma Specialities Ltd and was approved on Jun 23, 2023. And the latest generic version is by Gland Pharma Ltd and was approved on Mar 1, 2024.
Given below is the list of companies who have filed for Alcaftadine generic.
1. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Alcaftadine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | solution/drops | Discontinued | OPHTHALMIC | N/A | Jun 23, 2023 |
2. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Alcaftadine. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | solution/drops | Over the counter | OPHTHALMIC | N/A | Mar 1, 2024 |